SCHEMBL6893064

SCHEMBL6893064

COc1cccc(CNC(Cc2cc(F)cc(F)c2)[C@H](O)CNC(=O)c2cc(C)cc(-c3ccsc3)c2)c1

nearest known ligand 0.54

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
BACE1 P56817 20/20 0.54
BACE2 Q9Y5Z0 1/20 0.54
CTSD P07339 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3357959 0.89 BACE1 (0.68) BACE1BACE2CTSD
SCHEMBL3357965 0.89 BACE1 (0.68) BACE1BACE2CTSD
SCHEMBL3353181 0.81 BACE1 (0.66) BACE1BACE2CTSD
SCHEMBL3353178 0.81 BACE1 (0.66) BACE1BACE2CTSD
SCHEMBL6648928 0.81 BACE1 (0.54) BACE1BACE2
SCHEMBL3354246 0.78 BACE1 (0.72) BACE1BACE2CTSD
SCHEMBL3354242 0.78 BACE1 (0.72) BACE1BACE2CTSD
SCHEMBL3355738 0.75 BACE1 (0.77) BACE1BACE2CTSD
SCHEMBL3355743 0.75 BACE1 (0.77) BACE1BACE2CTSD
SCHEMBL5350790 0.74 BACE1 (0.79) BACE1BACE2CTSD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-2004502669-A 2004-01-29 JP claimed
EP-1353898-A2 COMPOUNDS TO TREAT ALZHEIMER'S DISEASE Elan Pharmaceuticals, Inc. (US) 2003-10-22 EP claimed
WO-2002002512-A2 COMPOUNDS TO TREAT ALZHEIMER'S DISEASE ELAN PHARMACEUTICALS, INC. (US) 2002-01-10 WO claimed